讲者二丙肝个体化治疗20090530__培训课件.pptVIP

* * Another way to look at this is to recall one of the basic tenets of HCV RNA therapy: If a patient is not negative for HCV RNA by Week?24, one can confidently discontinue treatment because there is virtually no chance of achieving SVR. However, there are many ways a patient can become negative for HCV RNA before Week?24, and the question is whether all these patients have the same likelihood of achieving SVR. The foregoing discussion suggests that the answer to this is no. To illustrate, this figure shows that a patient who achieves RVR and is treated for a full 48?weeks will have 44?week